Early clinical successes are becoming more common in oncology; and as a result, there is a need for endpoints that can meaningfully describe outcomes among treated patients. In cases where…
Broadstreet is pleased to be presenting several posters at this year’s virtual ISPOR Europe meeting. USE OF REAL-WORLD EVIDENCE TO EVALUATE INFLIXIMAB BIOSIMILARS: A SCOPING REVIEW Antoinette Cheung,1 Lauren Powell,1…
Broadstreet is pleased to be contributing to a greater understanding of the contemporary burden of Duchenne muscular dystrophy (DMD) with this new publication in the Journal of Managed Care and…
Broadstreet, collaborating with Bonnie Donato (Boehringer Ingelheim), has been looking at how high deductible health plans affect access to care in the US. Ahead of our upcoming journal publication on…
Our collaborative work with the Biohaven team on migraine continues to reveal new insights about the condition and we are pleased to have had some of our most recent research…
We’re very excited to announce the launch of our new website, a beautifully designed digital home that reflects who we are, what we do and how we’ve evolved over the…
Because we are epidemiologists, we often have people asking us questions about COVID-19 in general and about the vaccines in particular. Like many others, we have been awed and grateful…
VANCOUVER, BC, July 20 – Broadstreet Health Economics & Outcomes Research (HEOR), with Sprout Health Solutions, announced the publication of a study in Patient Preference and Adherence that provides new…
We are thrilled to be working with amazing collaborators to help understand the burden of Duchenne muscular dystrophy (DMD). Here is some of our recent research published in the Orphanet Journal…
Congratulations to Broadstreet team members Evan Popoff, Karissa Johnston and Lauren Powell. They, along with colleagues at Biohaven, Gilbert L’Italien, Linda Harris, Robert Croop, Alexandra Thiry, and Vladimir Coric, and…